• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦 1996-2017 年上皮性卵巢/输卵管癌的生存趋势:组织学和社会经济地位的影响。

Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.

机构信息

Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.

Survivorship and Inequality in Cancer, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100 Copenhagen; Denmark; National Institute of Public Health, University of Southern Denmark, Studiestræde 6, DK-1455 Copenhagen, Denmark.

出版信息

Gynecol Oncol. 2022 Jan;164(1):98-104. doi: 10.1016/j.ygyno.2021.10.091. Epub 2021 Nov 8.

DOI:10.1016/j.ygyno.2021.10.091
PMID:34763941
Abstract

OBJECTIVES

To examine time trends in ovarian/tubal cancer relative survival, excess mortality, and all-cause mortality for different histological types and levels of socioeconomic position.

METHODS

Women with ovarian/tubal cancer diagnosed 1996-2017 were identified in the Danish Cancer Registry (n = 11,755). Age-standardized 5-year relative survival over time was estimated by histology, socioeconomic status, and stage. Furthermore, 5-year excess mortality rate ratios (EMRR) according to calendar time for all categories of histology and socioeconomic status were calculated using a Poisson regression model. Finally, all-cause mortality by histology and socioeconomic status was estimated in multivariate Cox proportional hazards regression models.

RESULTS

Statistically significant improvements in 5-year relative survival occurred for all histological types over time except mucinous tumors (5-year EMRR, localized: 0.92 (95% CI: 0.71-1.16); advanced: 0.96 (95% CI: 0.85-1.08). Increase in relative survival over time and corresponding decrease in excess mortality was observed for all categories of socioeconomic status except for women with localized disease in the lowest income group (5-year EMRR = 0.91 (95% CI:0.76-1.10)). The impact of histology and socioeconomic status on all-cause mortality depended on time since diagnosis. Among the socioeconomic factors, especially low educational level and living alone were associated with increased all-cause mortality, particularly in the first year after diagnosis.

CONCLUSIONS

Ovarian/tubal cancer survival generally increased over time across histological types and socioeconomic factors. However, the lack of improvement for mucinous tumors needs further research. Additionally, the results for women with low income and education shows that continued focus on social equality in survival is necessary.

摘要

目的

研究不同组织学类型和社会经济地位水平的卵巢/输卵管癌相对生存率、超额死亡率和全因死亡率的时间趋势。

方法

在丹麦癌症登记处(n=11755)中确定了 1996-2017 年诊断为卵巢/输卵管癌的女性。通过组织学、社会经济地位和分期来估计随时间推移的年龄标准化 5 年相对生存率。此外,使用泊松回归模型计算了所有组织学类型和社会经济地位的按日历时间分类的 5 年超额死亡率比(EMRR)。最后,使用多变量 Cox 比例风险回归模型估计了按组织学和社会经济地位的全因死亡率。

结果

除黏液性肿瘤外,所有组织学类型的 5 年相对生存率均随时间显著提高(5 年 EMRR,局限性:0.92(95%CI:0.71-1.16);晚期:0.96(95%CI:0.85-1.08)。所有社会经济地位类别均观察到随时间推移的相对生存率提高和相应的超额死亡率下降,但收入最低组局限性疾病的女性除外(5 年 EMRR=0.91(95%CI:0.76-1.10))。组织学和社会经济地位对全因死亡率的影响取决于诊断后时间。在社会经济因素中,特别是低教育水平和独居与全因死亡率增加有关,尤其是在诊断后的头一年。

结论

卵巢/输卵管癌的生存率总体上随时间在所有组织学类型和社会经济因素中均有所提高。然而,黏液性肿瘤缺乏改善需要进一步研究。此外,低收入和低教育程度女性的结果表明,在生存方面继续关注社会平等是必要的。

相似文献

1
Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.丹麦 1996-2017 年上皮性卵巢/输卵管癌的生存趋势:组织学和社会经济地位的影响。
Gynecol Oncol. 2022 Jan;164(1):98-104. doi: 10.1016/j.ygyno.2021.10.091. Epub 2021 Nov 8.
2
Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.探讨医院登记数据在展示当地服务成果方面的附加价值:卵巢、输卵管和腹膜癌。
BMJ Open. 2019 Feb 19;9(2):e024036. doi: 10.1136/bmjopen-2018-024036.
3
Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.社会经济地位对非局部上皮性卵巢癌长期生存的预后影响——极端研究。
Gynecol Oncol. 2021 May;161(2):458-462. doi: 10.1016/j.ygyno.2021.01.042. Epub 2021 Feb 12.
4
Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.影响卵巢、输卵管或原发性腹膜癌女性短期死亡率的因素:基于英国国家癌症登记数据的人群队列分析
Int J Gynecol Cancer. 2016 Jan;26(1):56-65. doi: 10.1097/IGC.0000000000000562.
5
Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010.疾病分期、合并症或治疗可及性能否解释卵巢癌患者生存的社会经济差异?——一项针对2005年至2010年确诊的丹麦女性的队列研究。
Cancer Epidemiol. 2015 Jun;39(3):353-9. doi: 10.1016/j.canep.2015.03.011. Epub 2015 Apr 1.
6
Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.子宫切除术与侵袭性上皮性卵巢癌和输卵管癌的关联:英国 CTOCS 队列研究。
BJOG. 2022 Jan;129(1):110-118. doi: 10.1111/1471-0528.16943. Epub 2021 Oct 17.
7
Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.1997 - 2018年丹麦交界性卵巢肿瘤:按组织学、年龄和教育水平划分的发病率时间趋势
Acta Obstet Gynecol Scand. 2021 Mar;100(3):436-443. doi: 10.1111/aogs.14013. Epub 2020 Oct 21.
8
Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysis.卵巢癌、输卵管癌和原发性腹膜癌的发病、死亡和生存趋势:基于人群的 15 年分析。
Gynecol Oncol. 2024 May;184:190-197. doi: 10.1016/j.ygyno.2024.01.034. Epub 2024 Feb 7.
9
Ovarian and tubal cancer in Denmark: an update on incidence and survival.丹麦的卵巢癌和输卵管癌:发病率与生存率最新情况
Acta Obstet Gynecol Scand. 2016 Oct;95(10):1181-9. doi: 10.1111/aogs.12948. Epub 2016 Aug 20.
10
Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.丹麦卵巢癌患者的生存率:1978 - 2002年期间五年相对生存率的超额死亡风险分析
Acta Obstet Gynecol Scand. 2008;87(12):1353-60. doi: 10.1080/00016340802483000.

引用本文的文献

1
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial.尼拉帕利个体化起始剂量维持治疗铂敏感复发性卵巢癌患者(NORA):一项3期随机、安慰剂对照试验的最终总生存分析
EClinicalMedicine. 2024 May 7;72:102629. doi: 10.1016/j.eclinm.2024.102629. eCollection 2024 Jun.
2
Trends in survival of ovarian clear cell carcinoma patients from 2000 to 2015.2000年至2015年卵巢透明细胞癌患者的生存趋势。
Front Oncol. 2024 Mar 7;14:1360663. doi: 10.3389/fonc.2024.1360663. eCollection 2024.
3
Long-term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diagnosis: The extreme study.
诊断前使用绝经激素治疗的女性中非局部性上皮性卵巢癌的长期生存:极端研究。
Int J Cancer. 2022 Nov 1;151(9):1512-1522. doi: 10.1002/ijc.34171. Epub 2022 Jul 11.